Medical News

RSS

NIH awards Aestus $2M SBIR grant for clinical trials of treatment for chronic neuropathic pain

Aestus Therapeutics, Inc. announced that it has been awarded a $2 million Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH). The grant, from the NIH's National Institute of Neurological Disorders and Stroke (NINDS), will fund clinical trials of Aestus's novel, first-in-class treatment for chronic neuropathic pain.

9 Jun 2010

Hooper Holmes launches iParamed Expedite for insurance applications

Hooper Holmes today introduced iParamed Expedite, a new service that cuts costs and improves accuracy for insurance applications. It is six to seven days faster than current approaches and has been designed to quickly and accurately qualify applicants for life, long-term care, health and Medicare Supplement insurance policies.

9 Jun 2010

Caritas Christi Health Care implements MedAptus' Intelligent Charge Capture suite

MedAptus(R), the market leader for charge capture technologies, today announced that Caritas Christi Health Care, also based in Boston, has implemented the company's Intelligent Charge Capture suite for revenue and compliance enhancement initiatives. The organization selected MedAptus' Practice Plus Edition on BlackBerry smartphone devices and web-enabled workstations for the capture of physician inpatient charges. In addition, Caritas Christi is rolling out the MedAptus Facility Edition for the capture of outpatient clinic charges, starting in the area of cardiology.

9 Jun 2010

Helsinn Healthcare S.A., Eisai announce signing of licensing agreement

Helsinn Healthcare S.A. and Eisai Inc. today announce the signing of a licensing agreement granting Eisai Inc. commercialization rights for a new product for potential use in the prevention of chemotherapy-induced nausea and vomiting in the United States.

9 Jun 2010

Forest Laboratories announces $500M accelerated share repurchase program

Forest Laboratories, Inc. announced today that it has entered into an agreement with Morgan Stanley & Co. Incorporated to repurchase approximately $500 million of its common shares under an accelerated share repurchase program. Forest will acquire these common shares under the Board authorized 50 million share repurchase program announced on May 18, 2010.

9 Jun 2010

DST Health Solutions' latest version of CareAnalyzer released

Health plans, health management programs and healthcare providers can more accurately identify members, employees and patients who may benefit from targeted care management using the latest version of DSTHS CareAnalyzer®. Released today by DST Health Solutions, LLC, CareAnalyzer 4.1 is a comprehensive analytics software solution combining elements of patient risk, care opportunities and provider performance that helps organizations improve care management and meet reporting requirements for the Healthcare Effectiveness Data and Information Set (HEDIS).

9 Jun 2010

QuantRx Biomedical completes clinical testing of Q-Reader thyroid testing system

QuantRx Biomedical Corporation, a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today announced that it has completed clinical testing of the Q-Reader thyroid testing system.

9 Jun 2010

Cantel Medical board authorizes regular semiannual cash dividend

CANTEL MEDICAL CORP. announced today that its Board of Directors authorized a regular semiannual cash dividend of $0.05 per outstanding share of the Company's Common Stock. The dividend is payable on July 30, 2010 to shareholders of record at the close of business on July 15, 2010.

9 Jun 2010

Vemma kicks off second annual fundraising campaign for Children's Miracle Network

Vemma's second annual fundraising campaign for Children's Miracle Network kicks off this summer, June 1 - August 31, 2010. Funds raised will contribute to medical care, research and education throughout a network of 170 children's hospitals and foundations. Vemma NEXT, the company's liquid children's supplement, will play a key role in the fundraising effort.

9 Jun 2010

Clinical Data raises $27.8 million through common stock public offering

Clinical Data, Inc. today announced that it has raised gross proceeds of approximately $27.8 million through the public offering of 1,945,576 newly issued shares of its common stock at a price of $14.30 per share. All of the shares are being offered by Clinical Data, Inc., which exhausts all remaining shares on its existing shelf registration statement.

9 Jun 2010

Home Diagnostics, Nipro Diabetes announce merger to become Nipro Diagnostics

Home Diagnostics, Inc. and Nipro Diabetes Systems, Inc. today announced that the two companies will merge to become Nipro Diagnostics, Inc. Both companies are wholly-owned by Nipro Corporation, a multi-billion dollar company headquartered in Osaka, Japan and a world leader in providing medical products to the healthcare community.

9 Jun 2010

University Health Systems of Eastern Carolina licensed A.D.A.M. health tools for their hospital websites

A.D.A.M., Inc., a leading provider of health information and benefits technology solutions announced today that University Health Systems of Eastern Carolina has licensed the A.D.A.M. Multimedia Encyclopedia, Heart Center, and other A.D.A.M. health tools for eight of their hospital websites. The A.D.A.M. health information allows the system to provide more robust online health and wellness information to the counties served by the hospital system, and empowers people within those communities to lead healthier lives.

9 Jun 2010

Regeneron's ARCALYST prevents gout attacks in Phase 3 study of patients initiating allopurinol therapy

Regeneron Pharmaceuticals, Inc. announced that a Phase 3 study in gout patients initiating allopurinol therapy to lower their uric acid levels showed that ARCALYST (rilonacept), also known as IL-1 Trap, prevented gout attacks, as measured by the primary endpoint of the number of gout flares per patient over the 16 week treatment period.

9 Jun 2010

Home Run Challenge: PCF, MLB and MLBPA partner to raise funds for prostate cancer research

Major League Baseball players are putting their bats to work once again to help strike out prostate cancer as part of the Prostate Cancer Foundation's 14th Annual Home Run Challenge. The Home Run Challenge, a partnership between the Prostate Cancer Foundation, Major League Baseball and the Major League Baseball Players Association, begins today and runs through Father's Day, June 20, 2010.

9 Jun 2010

Interim results from PROPEL study of RG7128 submitted as abstract to AASLD for Annual Liver Meeting

Pharmasset, Inc. announced today that the interim results from the PROPEL study conducted by its partner Roche demonstrate that RG7128 triple combination therapy was safe and well tolerated. In that study, the safety profile of RG7128 (1000mg BID or 500mg BID), when administered for 8 or 12 weeks with Pegasys (peginterferon alfa-2a) and Copegus (ribavirin), the standard of care, was similar to the safety profile of SOC alone.

9 Jun 2010

Surgery through eyelids avoid major head trauma

Surgeons at Johns Hopkins have safely and effectively operated inside the brains of a dozen patients by making a small entry incision through the natural creases of an eyelid to reach the skull and deep brain.

9 Jun 2010

Researchers receive funding to study care processes in patients beginning dialysis

Researchers at the University of Cincinnati and the Cincinnati Department of Veterans Affairs (VA) Medical Center have received funding to study the care processes that lead to placement of arteriovenous fistulas in patients beginning dialysis.

9 Jun 2010

Sonomax signs MOU with ETS for $750,000 Industrial Research Chair

Sonomax Technologies Inc. signs a memorandum of understanding with the École de Technologie Supérieure (ETS) of the Université du Québec to create a five-year renewable $750,000 Industrial Research Chair to conduct unprecedented development of advanced in-ear technologies.

9 Jun 2010

Intellect Neurosciences receives Notice of Allowance from Israeli patent office for OXIGON drug candidate

Intellect Neurosciences, Inc announced it has received a Notice of Allowance from the Israeli Patent and Trademark Office for a new patent related to the Company's clinical-stage drug candidate OX1 (OXIGON), which has disease-modifying potential for Alzheimer's and other neurodegenerative disorders.

9 Jun 2010

Scientists develop algorithm to predict gene sequence of kinases

Kinexus Bioinformatics Corporation, a world-leader in molecular communications research, announced major advancements in its PhosphoNET KnowledgeBase for the study of cell signalling systems. This free resource to the scientific community now features data on more than 92,000 human phosphorylation sites, including their occurrence in over 20 other diverse species, and identification of the protein kinases that target these regulatory sites.

9 Jun 2010

Medical News

NIH awards Aestus $2M SBIR grant for clinical trials of treatment for chronic neuropathic pain

Hooper Holmes launches iParamed Expedite for insurance applications

Caritas Christi Health Care implements MedAptus' Intelligent Charge Capture suite

Helsinn Healthcare S.A., Eisai announce signing of licensing agreement

Forest Laboratories announces $500M accelerated share repurchase program

DST Health Solutions' latest version of CareAnalyzer released

QuantRx Biomedical completes clinical testing of Q-Reader thyroid testing system

Cantel Medical board authorizes regular semiannual cash dividend

Vemma kicks off second annual fundraising campaign for Children's Miracle Network

Clinical Data raises $27.8 million through common stock public offering

Home Diagnostics, Nipro Diabetes announce merger to become Nipro Diagnostics

University Health Systems of Eastern Carolina licensed A.D.A.M. health tools for their hospital websites

Regeneron's ARCALYST prevents gout attacks in Phase 3 study of patients initiating allopurinol therapy

Home Run Challenge: PCF, MLB and MLBPA partner to raise funds for prostate cancer research

Interim results from PROPEL study of RG7128 submitted as abstract to AASLD for Annual Liver Meeting

Surgery through eyelids avoid major head trauma

Researchers receive funding to study care processes in patients beginning dialysis

Sonomax signs MOU with ETS for $750,000 Industrial Research Chair

Intellect Neurosciences receives Notice of Allowance from Israeli patent office for OXIGON drug candidate

Scientists develop algorithm to predict gene sequence of kinases

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News